Macular Degeneration Treatment Global Market Report 2022 – By Stage of Disease (Early-Stage AMD, Intermediate AMD, Late-Stage AMD), By End-User (Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals), By Route of Administration (Oral, Injectable, Others), By Types (Wet Macular Degeneration, Dry Macular Degeneration) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 175 | Published : April 2022 | SKU CODE : | Delivery Time: 2-3 business days | Format :


The macular degeneration treatment market consists of sales of macular degeneration treatment by entities (organizations, sole traders, and partnerships) that are used to treat macular degeneration eye disease. Macula refers to the central portion of the retina, a light-sensitive layer of tissue at the backside of the eye. The macula is responsible for central vision. Degeneration of the macula, which affects the central part of the retina (the macula) and results in distortion or loss of central vision, occurs most commonly after the age of 60 and is referred to as age-related macular generation (AMD). Macular degeneration treatment helps to slow the disease and prevent severe loss of vision. 

The main disease stages of the macular degeneration treatment market are early-stage AMD, intermediate AMD, and late-stage AMD. In early-stage AMD, the macula changes, with medium-sized drusen deposits and no pigment changes, but does not impact vision. Intermediate AMD is when vision may get blurry or wavy with large drusen or pigment changes. In late-stage AMD, the central vision fails completely, causing vision loss. The different types of macular degeneration treatment include wet macular degeneration and dry macular degeneration. The different routes of administration of macular degeneration treatment include oral, injectable, and others used by different end-users such as ambulatory surgical centers, ophthalmic clinics, and hospitals. 

The global macular degeneration treatment market size is expected to grow from $7.55 billion in 2021 to $8.08 billion in 2022 at a compound annual growth rate (CAGR) of 7.04%. The growth in the market is mainly due to the companies' resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global macular degeneration treatment market size is expected to reach $10.65 billion in 2026 at a CAGR of 7.15%.

The increasing burden of retinal disorders is expected to propel the growth of the macular degeneration treatment market. Retinal disorders affect the vital tissue and affect the way individuals process visual information, leading to distorted or absent vision. According to a study done in Tanzania in 2020 about the prevalence of retinal diseases and associated risk factors, out of 1,007 people, the prevalence of vitreoretinal disorders was 22.8% (230/1,007). The study was conducted by OSLI Retina, which focuses solely on retinal diseases, surgery, and pharmacotherapy. The leading retinal diseases were age-related hypertensive macular scars (2.7%), retinopathy (4.5%), and degeneration (7.0%). According to the American Academy of Opthalmology, in 2050, an estimated 7.32 million people in the United States will have primary open-angle glaucoma, with the highest numbers among populations aged 70 to 79 years (32%), women (50%), and Hispanics (50%). The largest demographic group is Hispanic men. Therefore, the increasing burden of retinal disorders is driving the growth of the macular degeneration treatment market.

The development of advanced therapies is a key trend gaining popularity in the macular degeneration treatment market. Advanced therapy, including gene therapy, for the treatment of disease has seen development in recent years, particularly within the world of inherited retinal disease. For instance, in the year 2019, Spark Therapeutics, a USA-based gene therapy treatment company, developed Luxturna, which is a therapy designed to treat patients with mutations on a gene called RPE65, which encodes a retinal protein necessary for the eye in order to respond to light.

In September 2021, Novartis, a Swiss-based pharmaceutical company, acquired Arctos Medical for an undisclosed amount. The acquisition is expected to allow Novartis to find treatments for patients with vision loss and leverage the potential of optogenetics as the basis of successful therapeutics. Arctos Medical is a Switzerland-based developer of smart medical devices and gene therapy approaches for ophthalmological diseases for treating blindness.

Major players in the macular degeneration treatment market are Novartis AG, Bausch Health Companies Inc, Regenxbio Inc, F Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc, GlaxoSmithKline plc, Bayer AG, Neurotech Pharmaceuticals Inc, Ophthotech Corporation, StemCells Inc, Pfizer Inc, Santen Pharmaceuticals, Alimera Sciences Inc, Aerie Pharmaceutical Inc, Panoptica, Allergan Inc, Valeant Pharmaceuticals, and Rxi Pharmaceuticals.

In 2021, North America will be the largest region in the macular degeneration treatment market. Asia-Pacific is expected to be the fastest-growing region in the forecast period in the global macular degeneration treatment market. The regions covered in the global macular degeneration treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the macular degeneration treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The global macular degeneration treatment market market is segmented -

1) By Stage of Disease: Early-Stage AMD, Intermediate AMD, Late-Stage AMD

2) By End-User: Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals

3) By Route of Administration: Oral, Injectable, Others

4) By Type: Wet Macular Degeneration, Dry Macular Degeneration

    Table Of Contents

    1. Executive Summary

    2. Macular Degeneration Treatment Market Characteristics

    3. Macular Degeneration Treatment Market Trends And Strategies

    4. Impact Of COVID-19 On Macular Degeneration Treatment

    5. Macular Degeneration Treatment Market Size And Growth

    5.1. Global Macular Degeneration Treatment Historic Market, 2016-2021, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Macular Degeneration Treatment Forecast Market, 2021-2026F, 2031F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Macular Degeneration Treatment Market Segmentation

    6.1. Global Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Wet Macular Degeneration

    Dry Macular Degeneration

    6.2. Global Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Early-Stage AMD

    Intermediate AMD

    Late-Stage AMD

    6.3. Global Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Oral

    Injectable

    Others

    6.4. Global Macular Degeneration Treatment Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Ambulatory Surgical Centers

    Ophthalmic Clinics

    Hospitals

    7. Macular Degeneration Treatment Market Regional And Country Analysis

    7.1. Global Macular Degeneration Treatment Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    7.2. Global Macular Degeneration Treatment Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8. Asia-Pacific Macular Degeneration Treatment Market

    8.1. Asia-Pacific Macular Degeneration Treatment Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8.3. Asia-Pacific Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    9. China Macular Degeneration Treatment Market

    9.1. China Macular Degeneration Treatment Market Overview

    9.2. China Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    9.3. China Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    10. India Macular Degeneration Treatment Market

    10.1. India Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    10.2. India Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11. Japan Macular Degeneration Treatment Market

    11.1. Japan Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11.2. Japan Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12. Australia Macular Degeneration Treatment Market

    12.1. Australia Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12.2. Australia Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13. Indonesia Macular Degeneration Treatment Market

    13.1. Indonesia Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13.2. Indonesia Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14. South Korea Macular Degeneration Treatment Market

    14.1. South Korea Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14.2. South Korea Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15. Western Europe Macular Degeneration Treatment Market

    15.1. Western Europe Macular Degeneration Treatment Market Overview

    15.2. Western Europe Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15.3. Western Europe Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16. UK Macular Degeneration Treatment Market

    16.1. UK Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16.2. UK Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17. Germany Macular Degeneration Treatment Market

    17.1. Germany Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17.2. Germany Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18. France Macular Degeneration Treatment Market

    18.4. France Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18.5. France Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19. Eastern Europe Macular Degeneration Treatment Market

    19.1. Eastern Europe Macular Degeneration Treatment Market Overview

    19.2. Eastern Europe Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19.3. Eastern Europe Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20. Russia Macular Degeneration Treatment Market

    20.1. Russia Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20.2. Russia Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21. North America Macular Degeneration Treatment Market

    21.1. North America Macular Degeneration Treatment Market Overview

    21.2. North America Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21.3. North America Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22. USA Macular Degeneration Treatment Market

    22.1. USA Macular Degeneration Treatment Market Overview

    22.2. USA Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22.3. USA Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23. South America Macular Degeneration Treatment Market

    23.1. South America Macular Degeneration Treatment Market Overview

    23.2. South America Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23.3. South America Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24. Brazil Macular Degeneration Treatment Market

    24.1. Brazil Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24.2. Brazil Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25. Middle East Macular Degeneration Treatment Market

    25.1. Middle East Macular Degeneration Treatment Market Overview

    25.2. Middle East Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25.3. Middle East Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26. Africa Macular Degeneration Treatment Market

    26.1. Africa Macular Degeneration Treatment Market Overview

    26.2. Africa Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26.3. Africa Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    27. Macular Degeneration Treatment Market Competitive Landscape And Company Profiles

    27.1. Macular Degeneration Treatment Market Competitive Landscape

    27.2. Macular Degeneration Treatment Market Company Profiles

    27.2.1. Novartis AG

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Bausch Health Companies Inc

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Regenxbio Inc

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. F Hoffmann-La Roche Ltd

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Regeneron Pharmaceuticals Inc

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Macular Degeneration Treatment Market

    29. Macular Degeneration Treatment Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3: Global Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 4: Global Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 5: Global Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 6: Global Macular Degeneration Treatment Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Global Macular Degeneration Treatment Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Global Macular Degeneration Treatment Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: Asia-Pacific, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: Asia-Pacific, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: China, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12: China, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 13: India, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 14: India, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 15: Japan, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 16: Japan, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 17: Australia, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 18: Australia, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 19: Indonesia, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 20: Indonesia, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 21: South Korea, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 22: South Korea, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 23: Western Europe, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 24: Western Europe, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 25: UK, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 26: UK, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 27: Germany, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 28: Germany, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 29: France, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 30: France, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 31: Eastern Europe, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 32: Eastern Europe, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 33: Russia, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 34: Russia, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 35: North America, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 36: North America, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 37: USA, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 38: USA, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 39: South America, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 40: South America, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 41: Brazil, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 42: Brazil, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 43: Middle East, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 44: Middle East, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 45: Africa, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 46: Africa, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 47: Novartis AG Financial Performance
  • Table 48: Bausch Health Companies Inc Financial Performance
  • Table 49: Regenxbio Inc Financial Performance
  • Table 50: F Hoffmann-La Roche Ltd Financial Performance
  • Table 51: Regeneron Pharmaceuticals Inc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Figure 3: Global Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 4: Global Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 5: Global Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 6: Global Macular Degeneration Treatment Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7: Global Macular Degeneration Treatment Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8: Global Macular Degeneration Treatment Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9: Asia-Pacific, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10: Asia-Pacific, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11: China, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12: China, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 13: India, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 14: India, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 15: Japan, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 16: Japan, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 17: Australia, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 18: Australia, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 19: Indonesia, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 20: Indonesia, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 21: South Korea, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 22: South Korea, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 23: Western Europe, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 24: Western Europe, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 25: UK, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 26: UK, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 27: Germany, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 28: Germany, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 29: France, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 30: France, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 31: Eastern Europe, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 32: Eastern Europe, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 33: Russia, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 34: Russia, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 35: North America, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 36: North America, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 37: USA, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 38: USA, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 39: South America, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 40: South America, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 41: Brazil, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 42: Brazil, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 43: Middle East, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 44: Middle East, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 45: Africa, Macular Degeneration Treatment Market, Segmentation By Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 46: Africa, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 47: Novartis AG Financial Performance
  • Figure 48: Bausch Health Companies Inc Financial Performance
  • Figure 49: Regenxbio Inc Financial Performance
  • Figure 50: F Hoffmann-La Roche Ltd Financial Performance
  • Figure 51: Regeneron Pharmaceuticals Inc Financial Performance
Global Multiplex Assays Market Overview And Prospects
Global Consumer Healthcare Market Size, Forecasts, And Opportunities
Global Negative Pressure Wound Therapy Market Overview And Prospects
Global Biobank Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Podiatry Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Telemedicine Services Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Telemedicine Technologies Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Medication Adherence Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Diagnostic And Monitoring Ophthalmic Devices And Equipment Global Market Report 2022 – By Product Type (Optical coherence tomographers, Ophthalmic ultrasound imaging systems, Fundus cameras, Ophthalmoscopes, Keratometers, Specular microscopes., Tonometers, Slit Lamps, Retinoscopes), By End User (Hospitals, Clinics, Diagnostic Laboratories, Research Centers), By Application (Retinal evaluation, Glaucoma detection and monitoring, Surgical evaluation, General examine, Intraoperative devices, Refraction equipment) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Ophthalmic Devices Global Market Report 2022 – By Type (Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices And Equipment), By End User (Hospitals And Clinics, Diagnostic Laboratories), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Ophthalmic Medical Lasers Global Market Report 2022 – By Product (Diode Lasers, Femtosecond Lasers, Excimer Lasers Aromatherapy, ND:Yag Lasers, Other Products), By End User (Hospitals, Specialty Clinics and Ambulatory Surgery Centres), By Application (Refractive Error Correction, Cataract Removal, Diabetic Retinopathy, Glaucoma, Age-Related Macular Degeneration, Other Applications) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Cataract Surgery Devices And Equipment Global Market Report 2022 – By Type (Intraocular Lens (IOL), Ophthalmic viscoelastic device (OVD), Phacoemulsification Equipment, Femtosecond Laser Equipment), By Application (Ophthalmology Centers, Hospitals, Clinics), By Surgery Type (Extracapsular Cataract Extraction, Phacoemulsification, Femtosecond Laser, Other Surgery Types) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Vision Care Devices And Equipment Global Market Report 2022 – By Type (Intraocular Lens, Ophthalmic Lasers, Glaucoma Drainage Devices, Contact Lenses), By End-User (Hospitals, Ambulatory Surgery Centers, Optical Centers), By Application (Vision Care, Diagnosis, Surgery) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Intraocular Lens Global Market Report 2022 – By Type (Monofocal Intraocular Lens, Multifocal Intraocular Lens, Toric intraocular lens, Accommodating Intraocular Lens), By Material (Polymethylmethacrylate (PMMA), Silicone, Hydrophobic Acrylic), By End User (Hospitals, Ambulatory Surgery Centres, Ophthalmology Clinics, Eye Research Institutes) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Ophthalmology Drugs Global Market Report 2022 – By Type (Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Refractive Surgery Devices And Equipment Global Market Report 2022 – By Product Type (Microkeratome, Excimer Lasers, Femtosecond Lasers, YAG Lasers), By End User (Hospitals, Ambulatory Surgical Centres, Opthalmology Clinics), By Application (Astigmatism, Near-sightedness, Farsightedness) – Market Size, Trends, And Global Forecast 2022-2026
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)